American drugmaker Regeneron Pharmaceuticals is the subject of a legal action from the US Government, alleging kickbacks were paid to a charity to illegally pro 25 June 2020
Authorities in the UK have reclassified Epidyolex (cannabidiol) as a Schedule 5 drug, the lowest level of control, making it easier for the company to distribut 24 June 2020
US biotech Regeneron Pharmaceuticals has failed to invalidate a fifth Kymab patent, covering genetically modified mice used to produce human antibody therapeuti 3 June 2020
A legal challenge from healthcare professionals in the USA will seek to end “arbitrary interference” from the US regulator over the use of hydroxychloroquine (H 3 June 2020
Generic drugmaker Apotex has admitted to fixing the price of a widely-used cholesterol drug and has accepted a $24.1 million fine from a US court. 11 May 2020
A UK High Court ruling has invalidated patents held by San Francisco-based FibroGen, clearing the way for Akebia Therapeutics to proceed with a new class of med 20 April 2020
The US Food and Drug Administration has dropped an investigation into Novartis company AveXis, related to the novel spinal muscular atrophy (SMA) Zolgensma (ona 1 April 2020
Fish oil-based drug Vascepa (icosapent ethyl) could make a smaller splash than Amarin had hoped, after a US court nixed part of its patent estate. 31 March 2020
As the world watches aghast, the novel coronavirus continues to spread its tentacles around the globe, with cases of COVID-19 rising to nearly 375,000 on Tuesda 25 March 2020
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.